DNA Damage and Immunogenicity in Ewing Sarcoma
DNA Damage and Immunogenicity in Ewing Sarcoma
批准号:
10213196
负责人:
Kelly Bailey
金额:
$15.3万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2026-03-31
关键词:
Activated LymphocyteAddressAdolescentAdvanced Malignant NeoplasmAgonistAnimal ModelAntineoplastic ProtocolsAntitumor ResponseAreaAuthorshipAutomobile DrivingBARD1 geneBRCA1 geneBioinformaticsCD8-Positive T-LymphocytesCancer BiologyCell Surface ProteinsCell modelCellsCellular biologyChildhood Cancer TreatmentChimeric ProteinsCoculture TechniquesCombination immunotherapyCombined Modality TherapyCommittee MembersComplementComputer AnalysisCyclic GMPDNADNA DamageDNA RepairDataDefectDevelopment PlansDiagnosisDoxorubicinEWS-FLI1 fusion proteinEducational StatusEducational workshopEnvironmentEwings sarcomaFeedbackFosteringGene ActivationGerm-Line MutationGoalsGrantGrowthHumanIRF1 geneImmuneImmune checkpoint inhibitorImmune responseImmunobiologyImmunologyImmunotherapeutic agentImmunotherapyImpairmentIn VitroIndividualInfiltrationInflammatoryInterferon ActivationInvestigationK-Series Research Career ProgramsKnowledgeLaboratoriesLiteratureLocationMalignant Bone NeoplasmMalignant Childhood NeoplasmMalignant NeoplasmsManuscriptsMediatingMentorsMutationOncogenicPathway interactionsPatientsPediatric OncologistPediatric OncologyPhysiciansPoly(ADP-ribose) PolymerasesRadiationRegulationRelapseResearchSamplingScienceScientistSeasonsSignal TransductionSpecimenStimulator of Interferon GenesT cell responseT-LymphocyteTechnical ExpertiseTechniquesTestingTrainingTraining TechnicsTumor Cell BiologyTumor-Infiltrating LymphocytesTumor-infiltrating immune cellsUniversitiesUp-RegulationVocational GuidanceWomanWorkanti-tumor immune responseanticancer researchbasecancer cellcareercareer developmentcheckpoint inhibitioncheckpoint therapycytokinecytotoxic CD8 T cellsefficacy evaluationgene repairhomologous recombinationhumanized mouseimmune checkpointimmunogenicityimmunoregulationimprovedin vivoinhibitor/antagonistmalignant breast neoplasmmeetingsmouse modelneoplastic cellpatient subsetspre-clinicalprogrammed cell death ligand 1programsrecruitrepair functionresponseskillstumortumor DNAtumor immunologytumor-immune system interactions
中文摘要
这个职业发展奖的目标是让申请人扩大她的知识和技术专长
在肿瘤免疫学和生物信息学分析,以应用这些新技术的调查,
儿童癌症尤因肉瘤。复发性尤文肉瘤几乎是一致致命的,因此新的治疗方法
迫切需要采取各种办法。越来越多的基于免疫的疗法现在正在被纳入
儿科癌症治疗方案。因此,为了成为一个成功的临床科学家指导切割-
边缘研究计划在尤文肉瘤,这是至关重要的,申请人获得专业知识,在肿瘤
免疫生物学目前,对尤文肉瘤肿瘤免疫调节的了解很少,
微环境该提案涉及儿科癌症两个广泛重要方面的相互作用
研究:DNA损伤修复和肿瘤免疫反应。这项拟议的工作具体审查的能力
DNA损伤激活尤文肿瘤细胞免疫调节途径。拟议目标将利用一个
体外细胞共培养分析、体内肿瘤动物建模和人类样本分析的组合,
为了解决这个重要的问题。申请人选择了一位主要导师,他是
癌症中的免疫/炎症信号传导,以及具有T细胞生物学和高级
免疫学技术。此外,申请人还建立了一个医生-科学家职业指导
委员会和合作者网络,包括具有尤文肉瘤、人源化小鼠
模型,DNA损伤修复,肿瘤免疫微环境和生物信息学分析。作为一个团队,
导师,共同导师,委员会成员和合作者致力于为申请人提供
肿瘤免疫学和先进癌症生物学的技术培训,以及对赠款和
手稿和职业指导。主要导师和共同导师投入指导申请人
通过将她转变为手稿的高级作者,
帮助她建立一个独立的实验室,并鼓励她直接指导科学家和临床医生
在不同层次的培训。匹兹堡大学是一个优秀的环境,在其中发展一个
职业生涯和扩大肿瘤免疫生物学的研究计划。申请人的职业发展计划
充分利用匹兹堡的许多独特的课程,包括面对面的职业发展研讨会
与经验丰富的科学家,参与匹兹堡妇女在科学论坛,研究生水平的肿瘤
免疫生物学和生物信息学课程和机会,介绍正在进行的工作,
匹兹堡大学癌症免疫学项目会议。在热情的支持和卓越的
由于她的导师和合作导师的科学专业知识,申请人渴望获得肿瘤方面的专门培训
免疫生物学和生物信息学分析,并启动一个独立的研究生涯,作为一个儿科
他是匹兹堡大学研究尤因肉瘤的肿瘤学家。
英文摘要
The goal of this career development award is for the applicant to expand her knowledge and technical expertise
in tumor immunology and bioinformatic analyses in order to apply these new skills to investigation of the
childhood cancer Ewing sarcoma. Relapsed Ewing sarcoma is nearly uniformly fatal, and thus new treatment
approaches are desperately needed. A growing number of immune-based therapies are now being incorporated
into pediatric cancer treatment protocols. Thus, in order to be a successful clinician scientist directing a cutting-
edge research program in Ewing sarcoma, it is essential that the applicant gain expertise in tumor
immunobiology. Currently, very little is understood about regulation of the Ewing sarcoma tumor immune
microenvironment. This proposal addresses the interplay of two broadly important facets of pediatric cancer
research: DNA damage repair and tumor immune response. This proposed work specifically examines the ability
of DNA damage to activate Ewing tumor cell immunoregulatory pathways. The proposed aims will utilize a
combination of in vitro cell co-culture analyses, in vivo tumor animal modeling and human specimen analyses in
order to address this important topic. The applicant has chosen a primary mentor who is an expert in
immune/inflammatory signaling in cancer, and a co-mentor with expertise in T-cell biology and advanced
immunology techniques. Additionally, the applicant has constructed a physician-scientist career mentoring
committee and network of collaboartors including individuals with expertise in Ewing sarcoma, humanized mouse
models, DNA damage repair, the tumor immune-microenvironment, and bioinformatic analyses. As a team, the
mentor, co-mentor, committee members and collaborators are dedicated to providing the applicant with
technique training in tumor immunology and advanced cancer biology, as well as critical feedback on grants and
manuscripts and career guidance. The primary mentor and co-mentor are invested in guiding the applicant
toward a highly successful career as physician scientist by transitioning her to senior authorship on manuscripts,
preparing her to start an independent laboratory and encouraging her to directly mentor scientists and clinicians
at various levels of training. The University of Pittsburgh is an outstanding environment in which to develop a
career and expand a research program in tumor immunobiology. The applicant’s career development plan takes
full advantage of the many unique offerings at Pittsburgh including face-to-face career development workshops
with seasoned scientists, participation in the Pittsburgh Women in Science forum, graduate level tumor
immunobiology and bioinformatics courses and opportunities for presentation of work-in-progress at the
University of Pittsburgh Cancer Immunology Program meetings. With the enthusiastic support and exceptional
scientific expertise of her mentor and co-mentor, the applicant is eager to gain specific training in tumor
immunobiology and bioinformatic analyses and to launch an independent research career as a pediatric
oncologist physician scientist studying Ewing sarcoma at the University of Pittsburgh.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA Damage and Immunogenicity in Ewing Sarcoma
-
批准号:10360543
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2021
-
负责人:Kelly Bailey
-
依托单位:
DNA Damage and Immunogenicity in Ewing Sarcoma
-
批准号:10605340
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2021
-
负责人:Kelly Bailey
-
依托单位:
海外基金